325 related articles for article (PubMed ID: 1774958)
1. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
Shih LY; Chiu WF; Lee CT
Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
[TBL] [Abstract][Full Text] [Related]
2. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
[TBL] [Abstract][Full Text] [Related]
3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
4. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
5. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
6. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
Berer A; Jäger E; Sagaster V; Streubel B; Wimazal F; Sperr WR; Welterman A; Schwarzinger I; Frommlet F; Haas OA; Valent P; Lechner K; Geissler K; Ohler L
Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
[TBL] [Abstract][Full Text] [Related]
7. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
9. [The International Prognostic Scoring System for primary myelodysplastic syndrome].
Sisková M; Dohnalová A; Neuwirtová R; Pĕnicková J; Karban J; Cmunt E
Sb Lek; 2002; 103(3):333-8. PubMed ID: 12688177
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
13. [Factors influencing leukemic transformation in myelodysplastic syndrome].
Borbényi Z; Varga G; Bérczi M; Gurzó M
Orv Hetil; 1990 Jun; 131(23):1231-6, 1239-40. PubMed ID: 2199892
[TBL] [Abstract][Full Text] [Related]
14. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
17. [Culture of cells forming granulomonocytic colonies in bone marrow (GM-CFU) in myelodysplastic syndromes and their relation to hematological findings and FAB subtype].
García M; Sanz GF; Arriaga F; Pérez-Sirvent ML; Marty ML; Sanz MA
Sangre (Barc); 1991 Aug; 36(4):269-75. PubMed ID: 1776105
[TBL] [Abstract][Full Text] [Related]
18. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
19. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome].
Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H
Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097
[TBL] [Abstract][Full Text] [Related]
20. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
